GJB2 was over‐expressed in 65.5% (72/110) of tumor tissues and 51.8% (57/110) of normal tissues, while GJB3 was over‐expressed in 61.8% (68/110) and 48.2% (53/110) of the tumor and normal tissues. The gene discussed is GJB3; the disease is neoplasm.